A bit frustrating A I did say a while back that .155 would be...

A bit frustrating A I did say a while back that .155 would be the bottom and maybe we
we need to touch that again which would be frustrating as the news out of ASCO22 while being positive on so many cancer trials and might I add some compelling results I still believe rightly or not IMU is on to something and the cards are held close so take a positive out of the progress from the other BIOs because I believe our platforms are a cut above and I’m happy to wait for data to clarify the clinical results as frustrating as it is.The SP is currently at .16 and I have had a buy order in for over 2 weeks at .16 but never filled so not sure where we are heading from here but when need breaks I would rather be on the buy side than the sell.
DYOR and invest with what you may lose
$$